{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:00:22Z","timestamp":1785798022975,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004497","name":"KU Leuven Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Science Policy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jhepr.2021.100295","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T14:46:49Z","timestamp":1619102809000},"page":"100295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice"],"prefix":"10.1016","volume":"3","author":[{"given":"Robbert","family":"Boudewijns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100295_bib1","series-title":"Global Hepatitis Report","year":"2017"},{"key":"10.1016\/j.jhepr.2021.100295_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100295_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1053\/gast.2002.31887","article-title":"Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen","volume":"122","author":"Lau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100295_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S2468-1253(18)30308-X","article-title":"Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses","volume":"4","author":"Zhou","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100295_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2021.100295_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhepr.2021.100295_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2021.100295_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","article-title":"Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection","volume":"61","author":"Bertoletti","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100295_bib9","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2021.100295_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhepr.2021.100295_bib11","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.vaccine.2017.03.049","article-title":"Chronic hepatitis B: immunological profile and current therapeutic vaccines in clinical trials","volume":"35","author":"Lobaina","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2021.100295_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2468-1253(18)30007-4","article-title":"Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand","volume":"3","author":"Maini","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100295_bib13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","article-title":"The yellow fever 17D virus as a platform for new live attenuated vaccines","volume":"10","author":"Bonaldo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jhepr.2021.100295_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhepr.2021.100295_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2021.100295_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2021.100295_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41541-018-0092-2","article-title":"A\u00a0yellow fever\u2013Zika chimeric virus vaccine candidate protects against Zika\u00a0infection and congenital malformations in mice","volume":"3","author":"Kum","year":"2018","journal-title":"NPJ Vaccin"},{"key":"10.1016\/j.jhepr.2021.100295_bib18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/22221751.2020.1730709","article-title":"A\u00a0chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice","volume":"9","author":"Kum","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jhepr.2021.100295_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02494-19","article-title":"A\u00a0chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies","volume":"11","author":"Mishra","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.jhepr.2021.100295_bib20","doi-asserted-by":"crossref","first-page":"e1838","DOI":"10.21769\/BioProtoc.1838","article-title":"In\u00a0vivo OVA-specific cytotoxic CD8+ T cell killing assay","volume":"6","author":"Chaoul","year":"2016","journal-title":"Bio-protocol"},{"key":"10.1016\/j.jhepr.2021.100295_bib21","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2010.04.071","article-title":"Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii","volume":"28","author":"Stoyanov","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2021.100295_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41586-020-3035-9","article-title":"A\u00a0single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate","volume":"590","author":"Sanchez-Felipe","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2021.100295_bib23","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.1128\/JVI.02149-13","article-title":"Dynamic viral dissemination in mice infected with Yellow fever virus strain 17D","volume":"87","author":"Erickson","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100295_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/gutjnl-2014-308546","article-title":"Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues","volume":"65","author":"Fan","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100295_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.vaccine.2012.12.074","article-title":"A\u00a0novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice","volume":"31","author":"Buchmann","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2021.100295_bib26","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3201\/eid2508.181432","article-title":"17dd yellow fever revaccination and heightened long-term immunity in populations of disease-endemic areas, Brazil","volume":"25","author":"Campi-Azevedo","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhepr.2021.100295_bib27","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1586\/14760584.2013.836320","article-title":"Safety profile of the yellow fever vaccine Stamaril\u00ae: a 17-year review","volume":"12","author":"Cottin","year":"2013","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.jhepr.2021.100295_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010929","article-title":"Yellow fever vaccine for patients with HIV infection","volume":"1","author":"Barte","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jhepr.2021.100295_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vaccine.2014.10.004","article-title":"Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk\/benefit assessment","volume":"33","author":"Monath","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2021.100295_bib30","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2021.100295_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2014.11.004","article-title":"Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects","volume":"475","author":"Zhang","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jhepr.2021.100295_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2012.07.011","article-title":"Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus","volume":"96","author":"Akbar","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2021.100295_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/jvi.71.3.2192-2201.1997","article-title":"The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype","volume":"71","author":"Milich","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100295_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1872-034X.2008.00468.x","article-title":"HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"39","author":"Chen","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2021.100295_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2021.100295_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100295_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100295_bib38","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/JVI.02111-12","article-title":"A\u00a0vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice","volume":"87","author":"Cobleigh","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100295_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2021.100295_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","article-title":"The evolution and clinical impact of hepatitis B virus genome diversity","volume":"17","author":"Revill","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2021.100295_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1743-422X-8-127","article-title":"Biological and immunological characterization of recombinant Yellow fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8\u00a0+ T cell epitope at two distinct regions of the genome","volume":"8","author":"Nogueira","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.jhepr.2021.100295_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/39b41d98-b117-41cf-b5de-b8486a67b1cd","article-title":"Recombinant Yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruzi","volume":"8","author":"Nogueira","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jhepr.2021.100295_bib43","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1136\/gutjnl-2014-308041","article-title":"TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice","volume":"64","author":"Martin","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2021.100295_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J\u00a0Exp Med"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:27:48Z","timestamp":1762900068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2589555921000719"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100295","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100295"}}